Cargando…
Gene set predictor for post-treatment Lyme disease
Lyme disease (LD) is tick-borne disease whose post-treatment sequelae are not well understood. For this study, we enrolled 152 individuals with symptoms of post-treatment LD (PTLD) to profile their peripheral blood mononuclear cells (PBMCs) with RNA sequencing (RNA-seq). Combined with RNA-seq data f...
Autores principales: | Clarke, Daniel J.B., Rebman, Alison W., Fan, Jinshui, Soloski, Mark J., Aucott, John N., Ma’ayan, Avi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729821/ https://www.ncbi.nlm.nih.gov/pubmed/36384094 http://dx.doi.org/10.1016/j.xcrm.2022.100816 |
Ejemplares similares
-
Predicting Lyme Disease From Patients' Peripheral Blood Mononuclear Cells Profiled With RNA-Sequencing
por: Clarke, Daniel J. B., et al.
Publicado: (2021) -
Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
por: Rebman, Alison W., et al.
Publicado: (2020) -
The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome
por: Rebman, Alison W., et al.
Publicado: (2017) -
A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients
por: Morrissette, Madeleine, et al.
Publicado: (2020) -
Symptom heterogeneity and patient subgroup classification among US patients with post-treatment Lyme disease: an observational study
por: Rebman, Alison W, et al.
Publicado: (2021)